These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7603367)

  • 21. Evaluation of varicella zoster virus-specific cell-mediated immunity by using an interferon-γ enzyme-linked immunosorbent assay.
    Hayashida K; Ozaki T; Nishimura N; Gotoh K; Funahashi K; Nakane K; Gomi Y; Manabe S; Ishikawa T; Yamanishi K
    J Immunol Methods; 2015 Nov; 426():50-5. PubMed ID: 26232696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cooperation between CD16(Leu-11b)+ NK cells and HLA-DR+ cells in natural killing of herpesvirus-infected fibroblasts.
    Oh SH; Bandyopadhyay S; Miller DS; Starr SE
    J Immunol; 1987 Oct; 139(8):2799-802. PubMed ID: 2821120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The varicella-zoster virus induces apoptosis in vitro in subpopulations of primary human peripheral blood mononuclear cells.
    König A; Hömme C; Hauröder B; Dietrich A; Wolff MH
    Microbes Infect; 2003 Aug; 5(10):879-89. PubMed ID: 12919856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of varicella-zoster virus in blood mononuclear cells of patients with postherpetic neuralgia.
    Vafai A; Wellish M; Gilden DH
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2767-70. PubMed ID: 2833752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppressor of Cytokine Signaling 3 Expression Induced by Varicella-Zoster Virus Infection Results in the Modulation of Virus Replication.
    Choi EJ; Lee CH; Shin OS
    Scand J Immunol; 2015 Oct; 82(4):337-44. PubMed ID: 26072679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus.
    Park HB; Kim KC; Park JH; Kang TY; Lee HS; Kim TH; Jun JB; Bae SC; Yoo DH; Craft J; Jung S
    J Rheumatol; 2004 Nov; 31(11):2151-5. PubMed ID: 15517626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common expression of varicella-zoster viral glycoprotein antigens in vitro and in chickenpox and zoster vesicles.
    Weigle KA; Grose C
    J Infect Dis; 1983 Oct; 148(4):630-8. PubMed ID: 6313814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A human monoclonal antibody against varicella-zoster virus glycoprotein III.
    Sugano T; Tomiyama T; Matsumoto Y; Sasaki S; Kimura T; Forghani B; Masuho Y
    J Gen Virol; 1991 Sep; 72 ( Pt 9)():2065-73. PubMed ID: 1654371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ORF61 Protein Encoded by Simian Varicella Virus and Varicella-Zoster Virus Inhibits NF-κB Signaling by Interfering with IκBα Degradation.
    Whitmer T; Malouli D; Uebelhoer LS; DeFilippis VR; Früh K; Verweij MC
    J Virol; 2015 Sep; 89(17):8687-700. PubMed ID: 26085158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulated Glycoprotein B-Mediated Cell-Cell Fusion Disrupts Varicella-Zoster Virus and Host Gene Transcription during Infection.
    Oliver SL; Yang E; Arvin AM
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB.
    Kitamura K; Namazue J; Campo-Vera H; Ogino T; Yamanishi K
    Virology; 1986 Feb; 149(1):74-82. PubMed ID: 2418583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ability of yeast Ty-VLPs (virus-like particles) containing varicella-zoster virus (VZV)gE and assembly protein fragments to induce in vitro proliferation of human lymphocytes from VZV immune patients.
    Welsh MD; Harper DR; Garcia-Valcarcel M; Fowler WJ; Aitken C; Jeffries DJ; Layton GT
    J Med Virol; 1999 Sep; 59(1):78-83. PubMed ID: 10440812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster.
    Chen JJ; Zhu Z; Gershon AA; Gershon MD
    Cell; 2004 Dec; 119(7):915-26. PubMed ID: 15620351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infectibility of separated peripheral blood mononuclear cell subpopulations by varicella-zoster virus (VZV).
    Koenig A; Wolff MH
    J Med Virol; 2003; 70 Suppl 1():S59-63. PubMed ID: 12627490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human leukocytes kill varicella-zoster virus-infected fibroblasts in the presence of murine monoclonal antibodies to virus-specific glycoproteins.
    Ito M; Ihara T; Grose C; Starr S
    J Virol; 1985 Apr; 54(1):98-103. PubMed ID: 2983124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different antigens trigger different Th1/Th2 reactions in neonatal mononuclear cells (MNCs) relating to T-bet/GATA-3 expression.
    Yu HR; Chang JC; Chen RF; Chuang H; Hong KC; Wang L; Yang KD
    J Leukoc Biol; 2003 Nov; 74(5):952-8. PubMed ID: 12960249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular and humoral immunity to varicella zoster virus glycoproteins in immune and susceptible human subjects.
    Giller RH; Winistorfer S; Grose C
    J Infect Dis; 1989 Dec; 160(6):919-28. PubMed ID: 2555419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discordant varicella-zoster virus glycoprotein C expression and localization between cultured cells and human skin vesicles.
    Storlie J; Carpenter JE; Jackson W; Grose C
    Virology; 2008 Dec; 382(2):171-81. PubMed ID: 18954885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid effector function of varicella-zoster virus glycoprotein I-specific CD4+ T cells many decades after primary infection.
    Malavige GN; Jones L; Black AP; Ogg GS
    J Infect Dis; 2007 Mar; 195(5):660-4. PubMed ID: 17262706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.